RBP4 and LCN2 correlate with insulin resistance and cardiovascular disease burden, and elevated circulating levels predict adverse outcomes and event severity in CAD populations [93,94,95,111,112,113,114,115]. This evidence concerns the gene LCN2 and coronary artery disorder.